The Potential Effect of Ubai-en on Protein-losing Enteropathy.
10.3937/kampomed.53.229
- VernacularTitle:蛋白漏出性腸症に対する烏梅円の使用経験とその方意について
- Author:
Kazuaki IMAI
;
Mosaburou KAINUMA
;
Kazufumi KOHTA
;
Tadamichi MITSUMA
- Publication Type:Journal Article
- Keywords:
Ubai-en;
protein-losing enteropathy;
rheumatoid arthritis;
GI tract amyloidosis;
anti-ascarid drug
- From:Kampo Medicine
2002;53(3):229-234
- CountryJapan
- Language:Japanese
-
Abstract:
A 64-year-old female who had suffered from rheumatoid arthritis (RA) for many years was admitted to our hospital because of acute abdominal pain and diarrhea. She was diagnosed with RA, Sjögren syndrome and protein-losing enteropathy (PLE) with GI tract amyloidosis. She was treated with total parenteral nutrition, prednisolone, tranexamic acid and a variety of Kampo medicines, for example: kanzo-syashin-to, keishi-kashakuyaku-shoukyou-ninjin-to, and bushi-kobei-to. However, diarrhea continued and paralytic ileus occurred. Then she was treated with Ubai-en, which is known as an anti-ascarid drug or anti-diarrheic drug. Ubai-en was effective on her diarrhea in 2 weeks. This suggests that Ubai-en may be an effective treatment for PLE.
